Tci Gene Inc.TPEX: 6879

Correction the information of "The basis and reasonableness of the private placement pricing" on M.O.P.S.

· Issued by Tci Gene Inc.
Close
Today's Information

Provided by: TCI GENE INC
SEQ_NO 7 Date of announcement 2022/03/17 Time of announcement 23:46:22
Subject
 Correction the information of "The basis and
reasonableness of the private placement pricing" on
M.O.P.S.
Date of events 2022/03/17 To which item it meets paragraph 27
Statement
1.Date of occurrence of the event:2022/03/17
2.Company name: TCI GENE INC
3.Relationship to the Company (please enter "head office"
or "subsidiaries"):head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:
 (1)Correction the content of 2022 Special Shareholders Meeting of Proposed
    Resolutions 1 "Proposal for a cash offering by private placement" for
    the "The basis and reasonableness of the private placement pricing".
 (2)Previous information: "For the 30 business days preceding the price
    determination date, or the sum of all transaction amounts of the common
    shares of such emerging stock traded on each of those business days in
    the Emerging Stock".
 (3)Correction information: Base on the "Direction for Public Companies
    Conducting Private Placements of Securities", correct to "For the 30
    business days preceding the price determination date, the simple
    arithmetic mean closing price of the common shares, or the sum of all
    transaction amounts of the common shares of such emerging stock traded
    on each of those business days in the Emerging Stock".
6.Countermeasures: Shareholders proposed to correct the content of the
 description of the proposed Resolutions 1.
7.Any other matters that need to be specified: Announcement of material
 information, and apply to correction the information of " The basis and
 reasonableness of the private placement pricing" on M.O.P.S.